Route 92 Medical, Inc. — SEC Form D Filing

Route 92 Medical, Inc. filed an SEC Form D on April 20, 2026, reporting $50.00M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
April 20, 2026
Amount reported
$50.00M
Round stage
Seed
Industry
Health Care
Website
https://www.route92medical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Current approaches to neurointervention have limitations, including ineffective navigation through complex anatomy and high failure rates in reaching target locations.

Solution

Route 92 Medical overcomes these limitations with innovative catheter systems designed for superior performance in challenging anatomies.

Why now

There is a growing need for more effective neurovascular intervention solutions as existing methods are insufficient for optimal patient outcomes.

Verdict

Investors said yes to Route 92 Medical because they recognized the urgent need for improved neurointervention solutions, betting on its innovative catheter systems to address significant shortcomings in traditional methods. This narrative cleared because it presented a clear problem-solution fit in an underserved medical field, not solely because of the technical novelty of the product. However, limited upside exists due to the inherent risks in medical device markets and the challenge of proving efficacy amid existing competitive devices.

Source: SEC EDGAR Form D filing